These genetic factors as well as clinico-pathological factors such as tumor stage, node stage, extramural venous invasion (EMVI), serum carcinoembryonic antigen (CEA) levels, tumor differentiation, and tumor size are known to be useful indicators for predicting prognosis [6,7]. This evidence concerns the gene CEACAM5 and neoplasm.